These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28273745)

  • 1. Histogram analysis of apparent diffusion coefficient for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
    Meng J; Zhu L; Zhu L; Ge Y; He J; Zhou Z; Yang X
    Acta Radiol; 2017 Nov; 58(11):1400-1408. PubMed ID: 28273745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
    Meng J; Zhu L; Zhu L; Wang H; Liu S; Yan J; Liu B; Guan Y; Ge Y; He J; Zhou Z; Yang X
    Radiat Oncol; 2016 Oct; 11(1):141. PubMed ID: 27770816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
    Erbay G; Onal C; Karadeli E; Guler OC; Arica S; Koc Z
    Acta Radiol; 2017 Apr; 58(4):481-488. PubMed ID: 27445314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging.
    Zhu L; Zhu L; Shi H; Wang H; Yan J; Liu B; Chen W; He J; Zhou Z; Yang X; Liu T
    BMC Cancer; 2016 Feb; 16():79. PubMed ID: 26860361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy.
    Perucho JAU; Wang M; Tse KY; Ip PPC; Siu SWK; Ngan HYS; Khong PL; Lee EYP
    Eur Radiol; 2021 Mar; 31(3):1727-1735. PubMed ID: 32885298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study.
    Xu Y; Zhu L; Liu B; Ru T; Wang H; He J; Liu S; Yang X; Zhou Z; Liu T
    BMC Cancer; 2017 Jun; 17(1):427. PubMed ID: 28629386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonic histogram assessment of early response to concurrent chemo-radiotherapy in patients with locally advanced cervical cancer: a feasibility study.
    Xu Y; Ru T; Zhu L; Liu B; Wang H; Zhu L; He J; Liu S; Zhou Z; Yang X
    Clin Imaging; 2018; 49():144-149. PubMed ID: 29414509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
    Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
    Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting and Early Monitoring Treatment Efficiency of Cervical Cancer Under Concurrent Chemoradiotherapy by Intravoxel Incoherent Motion Magnetic Resonance Imaging.
    Zhu L; Zhu L; Wang H; Yan J; Liu B; Chen W; He J; Zhou Z; Yang X
    J Comput Assist Tomogr; 2017; 41(3):422-429. PubMed ID: 27824669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of histogram analysis of apparent diffusion coefficient with uterine cervical pathologic finding.
    Lin Y; Li H; Chen Z; Ni P; Zhong Q; Huang H; Sandrasegaran K
    AJR Am J Roentgenol; 2015 May; 204(5):1125-31. PubMed ID: 25905952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-lesion ADC histogram and texture analysis in predicting recurrence of cervical cancer treated with CCRT.
    Meng J; Zhu L; Zhu L; Xie L; Wang H; Liu S; Yan J; Liu B; Guan Y; He J; Ge Y; Zhou Z; Yang X
    Oncotarget; 2017 Nov; 8(54):92442-92453. PubMed ID: 29190929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional power Doppler ultrasound in the early assessment of response to concurrent chemo-radiotherapy for advanced cervical cancer.
    Xu Y; Zhu L; Ru T; Wang H; He J; Zhou Z; Yang X
    Acta Radiol; 2017 Sep; 58(9):1147-1154. PubMed ID: 28068824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?
    Bae JM; Kim CK; Park JJ; Park BK
    Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
    Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
    Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer.
    Kuang F; Yan Z; Wang J; Rao Z
    Magn Reson Imaging; 2014 May; 32(4):342-9. PubMed ID: 24512795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.
    Kim HS; Kim CK; Park BK; Huh SJ; Kim B
    J Magn Reson Imaging; 2013 Jan; 37(1):187-93. PubMed ID: 23018989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early treatment response of patients undergoing concurrent chemoradiotherapy for cervical cancer: An evaluation of integrated multi-parameter PET-IVIM MR.
    Xu C; Sun H; Du S; Xin J
    Eur J Radiol; 2019 Aug; 117():1-8. PubMed ID: 31307633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy.
    Gu KW; Kim CK; Choi CH; Yoon YC; Park W
    Eur Radiol; 2019 Nov; 29(11):6236-6244. PubMed ID: 30980126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.